Research

Breast cancer research trials

Mercy General Hospital is participating in the following breast cancer research trials. For more information about specific trial qualifications, click on the individual trial name.

IBCSG-24-02
A phase III trial evaluating the role of ovarian function suppression and the role of exemustane as adjuvant therapies for premenopausal women with endocrine responsive breast cancer

GENENTECH AVF3693g
A phase III, randomized, placebo-controlled trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy regimens in subjects with previously treated metastatic breast cancer

GSK-EGF-108916
An open-label multicenter study of lapatinib in combination with chemotherapy in patients with ErbB2 overexpressing breast cancer after trastuzumab failure in the neoadjuvant or adjuvant setting

For more information, contact Rhoda Pineda, BS, CCRP Research Coordinator at (916) 453-4651